Whitehawk Therapeutics (WHWK) Short Interest Ratio & Short Volume $1.99 -0.02 (-1.00%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock Whitehawk Therapeutics Short Interest DataWhitehawk Therapeutics (WHWK) has a short interest of 242,700 shares, representing 0.93% of the float (the number of shares available for trading by the public). This marks a -17.59% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.1, indicating that it would take 2.1 days of the average trading volume of 148,033 shares to cover all short positions.Current Short Interest242,700 sharesPrevious Short Interest294,500 sharesChange Vs. Previous Month-17.59%Dollar Volume Sold Short$438.07 thousandShort Interest Ratio2.1 Days to CoverLast Record DateAugust 31, 2025Outstanding Shares47,128,000 sharesFloat Size26,190,000 sharesShort Percent of Float0.93%Today's Trading Volume242,266 sharesAverage Trading Volume148,033 sharesToday's Volume Vs. Average164% Short Selling Whitehawk Therapeutics? Sign up to receive the latest short interest report for Whitehawk Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartWHWK Short Interest Over TimeWHWK Days to Cover Over TimeWHWK Percentage of Float Shorted Over Time Whitehawk Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/2025242,700 shares $438.07 thousand No Change0.9%2.1 $1.81 WHWK Short Interest - Frequently Asked Questions What is Whitehawk Therapeutics' current short interest? Short interest is the volume of Whitehawk Therapeutics shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 242,700 shares of WHWK short. 0.93% of Whitehawk Therapeutics' shares are currently sold short. Learn More on Whitehawk Therapeutics' current short interest. What is a good short interest ratio for Whitehawk Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. WHWK shares currently have a short interest ratio of 2.0. Learn More on Whitehawk Therapeutics's short interest ratio. What is a good short interest percentage for Whitehawk Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.93% of Whitehawk Therapeutics' floating shares are currently sold short. Is Whitehawk Therapeutics' short interest increasing or decreasing? Whitehawk Therapeutics saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 242,700 shares, a decrease of 17.6% from the previous total of 294,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Whitehawk Therapeutics' float size? Whitehawk Therapeutics currently has issued a total of 47,128,000 shares. Some of Whitehawk Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Whitehawk Therapeutics currently has a public float of 26,190,000 shares. How does Whitehawk Therapeutics' short interest compare to its competitors? 0.93% of Whitehawk Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Whitehawk Therapeutics: Korro Bio, Inc. (22.77%), Altimmune, Inc. (31.73%), 4D Molecular Therapeutics, Inc. (10.18%), Upexi, Inc. (10.49%), Tectonic Therapeutic, Inc. (24.46%), Larimar Therapeutics, Inc. (8.10%), Galectin Therapeutics Inc. (18.18%), Amarin Corporation PLC (2.06%), Foghorn Therapeutics Inc. (3.07%), Ocugen, Inc. (19.52%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($73.23 billion), Invesco QQQ ($29.52 billion), iShares Russell 2000 ETF ($20.82 billion), iShares 20+ Year Treasury Bond ETF ($10.76 billion), Palo Alto Networks, Inc. ($9.37 billion), Strategy Inc ($7.58 billion), Invesco S&P 500 Equal Weight ETF ($6.78 billion), SPDR S&P Biotech ETF ($6.72 billion), AppLovin Corporation ($6.37 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($6.29 billion). View all of the most shorted stocks. What does it mean to sell short Whitehawk Therapeutics stock? Short selling WHWK is an investing strategy that aims to generate trading profit from Whitehawk Therapeutics as its price is falling. WHWK shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Whitehawk Therapeutics? A short squeeze for Whitehawk Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of WHWK, which in turn drives the price of the stock up even further. How often is Whitehawk Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including WHWK, twice per month. The most recent reporting period available is August, 31 2025. More Short Interest Resources from MarketBeat Related Companies Korro Bio Short Squeeze Altimmune Short Squeeze 4D Molecular Therapeutics Short Squeeze Upexi Short Squeeze Tectonic Therapeutic Short Squeeze Larimar Therapeutics Short Squeeze Galectin Therapeutics Short Squeeze Amarin Short Squeeze Foghorn Therapeutics Short Squeeze Ocugen Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:WHWK) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored6-Figure Target for BTC by 2025Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredThe $17B signal no one expected…After SpaceX struck a $17 billion deal with EchoStar for a block of radio frequencies, tech analyst Jeff Brown...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Whitehawk Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Whitehawk Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.